Insmed (INSM) is a publicly traded Healthcare sector company. As of November 17, 2026, INSM trades at $122.06 with a market cap of $26.58B and a P/E ratio of -24.27. INSM moved -0.67% today. Year to date, INSM is -30.61%; over the trailing twelve months it is -36.39%. Its 52-week range spans $60.40 to $212.75. Analyst consensus is strong buy with an average price target of $190.50. Rallies surfaces INSM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for INSM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $122.06 |
| Market Cap | $26.58B |
| P/E Ratio | -24.27 |
| EPS | $-4.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $212.75 |
| 52-Week Low | $60.40 |
| Volume | 8.07K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.14B |
| Net Income | $-875.31M |
| Gross Margin | 83.45% |
17 analysts cover INSM: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $190.50.